ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $224,094 | -11.8% | 5,525 | 0.0% | 0.02% | +155.6% |
| Q1 2022 | $254,000 | -30.6% | 5,525 | 0.0% | 0.01% | -30.8% |
| Q4 2021 | $366,000 | +1.4% | 5,525 | -4.4% | 0.01% | -7.1% |
| Q3 2021 | $361,000 | -24.5% | 5,777 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $478,000 | +24.8% | 5,777 | 0.0% | 0.02% | +38.5% |
| Q1 2021 | $383,000 | -13.5% | 5,777 | 0.0% | 0.01% | -35.0% |
| Q4 2020 | $443,000 | +70.4% | 5,777 | -4.2% | 0.02% | +81.8% |
| Q3 2020 | $260,000 | 0.0% | 6,031 | 0.0% | 0.01% | -21.4% |
| Q2 2020 | $260,000 | – | 6,031 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |